A new study by Transparency Market Research (TMR), titled “Bone Marrow Transplant Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024,” states that the...

A new study by Transparency Market Research (TMR), titled “Bone Marrow Transplant Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024,” states that the increasing prevalence of thalassemia and various types of blood cancers is fueling the demand for bone marrow transplants across the world.

The advancement in healthcare infrastructure worldwide has boosted the global bone marrow transplant market in the recent times. The rise in the disposable income of people, enabling them to afford these expensive treatments, is likely to propel this market significantly over the forecast period.

The global market for bone marrow transplant has been evaluated on the basis of the type of transplant, end user, type of disease, and the region in this research report. By the type of transplant, allogeneic bone marrow transplant and autologous bone marrow transplant have been identified as the key segments of this market. Autologous bone marrow transplants enjoy greater demand than allogeneic bone marrow transplants and this trend is likely to continue over the forecast period.

Based on end user, the market has been classified into hospitals, ambulatory surgery centers, and multispecialty clinics. The demand for bone marrow transplants is the highest in hospitals and is likely to remain so during the forecast period, notes the market study.

By the type of disease, the market has been segmented into blood cancer and blood disorders in the study. The global market is dominated by the blood cancer segment, in which the highest demand for these transplants is for the treatment of leukemia.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11237

Regionally, the report has categorized the market into Europe, Asia Pacific, North America, and the Rest of the World. Europe has been leading the global market for bone marrow transplants since last few years. The presence of an excellent healthcare infrastructure and rise in the spending power of individuals have prompted companies functional in the Europe medical and healthcare industry to include bone marrow transplants to their product portfolios, driving the growth of this market in Europe.

Analysts project this regional market to maintain its dominance over the forecast period. Other regional markets are also anticipated to exhibit significant growth in the coming years, reports the research study.

The study also presents an analysis of the competitive landscape prevailing in the worldwide bone marrow transplant market by profiling the key market players. Merck Millipore Corp., Sanofi-Aventis LLC., American Type Culture Collection (ATCC) Inc., AllCells LLC, STEMCELL Technologies., and Lonza Group Ltd. are the leading companies in the global bone marrow transplant market, states the research report.

Article Tags: Global Bone Marrow, Bone Marrow Transplant, Marrow Transplant Market, Bone Marrow Transplants, Global Bone, Bone Marrow, Marrow Transplant, Transplant Market, Blood Cancer, Marrow Transplants, Forecast Period, Global Market